While much of the recent GLP-1 saga has been written in the U.S., Novo Nordisk continues to expand its semaglutide empire ...

Staff in the Senate Health, Education, Labor, and Pensions (HELP ... putting the drug in scope. The report (PDF) notes that if Novo Nordisk charged the same for Wegovy in the US as it does ...